Private Foundation

Translational Research in Oncology-US FKA Translational Onc Res Intl Inc

Based in Los Angeles, CA, Translational Research in Oncology-US FKA Translational Onc Res Intl Inc operates as a Private Foundation. The organization reported $9.7M in revenue, $9.6M in expenses, $25.8M in total assets for fiscal year 2024.

EIN: 200132719 Los Angeles, CA Latest filing: 2024

Total Revenue$9.7M

Total Expenses$9.6M

Total Assets$25.8M

Grants Given0

Filing Years2019–2024

Officers & Directors

President/Se Dennis Slamon

Vice President John Glaspy

COO Meghan Brennan

CFO Shannon Ibara

Officer compensation and complete director data available with membership.

Financial Trends

Year	Revenue	Expenses	Assets
2024	$9.7M	$9.6M	$25.8M
2023	$8.4M	$8.5M	$24.6M
2022	$9.6M	$6.8M	$22.8M
2020	$7.6M	$6.9M	$22.0M
2019	$6.8M	$6.0M	$20.9M

Between 2019 and 2024, reported annual revenue grew from $6.8M to $9.7M (+42%), with total assets most recently reported at $25.8M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for Translational Research in Oncology-US FKA Translational Onc Res Intl Inc

Complete financials, all 0 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 498,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports